Related Experiment Video

Updated: Sep 4, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Prediction of allosteric druggable pockets of cyclin-dependent kinases

Shangbo Ning1, Huiwen Wang2, Chen Zeng3

  • 1Institute of Biophysics and Department of Physics, Central China Normal University, Wuhan, 430079, China.

Briefings in Bioinformatics
|July 13, 2022
PubMed

Insights

Identifying new drug targets is crucial for cancer therapy. This study introduces NetPocket, a network-based method to find allosteric pockets in cyclin-dependent kinases (Cdks) for more specific cancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Cyclin-dependent kinases (Cdks) are key regulators of the cell cycle and implicated in cancer.
  • Current Cdk inhibitors targeting the ATP pocket lack specificity, causing side effects.
  • Targeting allosteric pockets offers a strategy for developing more selective Cdk inhibitors.

Purpose of the Study:

  • To systematically identify and characterize druggable allosteric pockets in Cdks.
  • To address the limitations of existing Cdk inhibitor strategies.
  • To advance the development of targeted cancer therapies.

Main Methods:

  • A network-based pocket prediction approach (NetPocket) was developed.
  • NetPocket was used to systematically identify allosteric druggable pockets in Cdks.
  • Case studies were employed to illustrate the utility of NetPocket.

Main Results:

  • The study summarizes existing Cdk pockets and their selectivity.
  • NetPocket successfully identified potential allosteric druggable pockets.
  • The approach demonstrated utility in systematically analyzing these pockets.

Conclusions:

  • Allosteric pockets represent a promising avenue for developing selective Cdk inhibitors.
  • NetPocket provides a valuable tool for the systematic discovery of these pockets.
  • Further research is needed to explore the therapeutic potential and challenges of targeting allosteric Cdk pockets.
Keywords:
bioinformaticscomputational biophysicsdrug design

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.8K
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

10.6K

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.3K